Up a level |
(2023) Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS. Current medicinal chemistry. pp. 1406-1419. ISSN 0929-8673
(2022) Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS. Journal of Intensive Care. p. 20. ISSN 2052-0492